At a glance
ClinicalIndex Comparison RecordN/ACompleted· 60 enrolled
Drug / intervention
Syntocinon +3 moredrug
Likely dose
Syntocinon 32 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
The Effect of Intranasal Oxytocin on Headache Intensity and Headache-associated Symptoms in Patients Suffering From Chronic Daily Headache
In Brief
A clinical study evaluating Syntocinon and Sterile water for Chronic Daily Headache. Completed, enrolled 60 participants across 1 site.
Detailed Summary
The objective of this prospective, randomized, double-blind, parallel-group, placebo-controlled study is to determine the effectiveness of intranasal oxytocin in subjects suffering from chronic daily headache.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Daily Headache
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedAug 2009
Enrollment StartNov 2009
Primary CompletionAug 2010
TodayJul 2026
First PostedAug 20, 2009
Enrollment StartNov 1, 2009
Primary CompletionAug 1, 2010
TodayJul 2, 2026
Enrollment to primary: 9 monthsPosted 16.9 years ago
Interventions
Syntocinondrug
4 actuations in each nostril for a total dose of 32 IU
Sterile waterdrug
4 actuations in each nostril
Syntocinondrug
8 actuations in each nostril for a total dose of 64 IU
Sterile waterdrug
8 actuations in each nostril